PartnerFacts
Data last updated: Oct 23, 2026, 5:45 PM ETLatest filing: Oct 22, 2026Now: Oct 24, 2026, 5:18 AM ET

Sponsor Check › Person

TM
No photo found yet (own website and image search run after this page is viewed)

Thomas Monath

Named as an officer, director or promoter on SEC Form D filings · MA, NJ, TN · Feb 4, 2011 → Feb 4, 2011

3deals (issuers)
$27.8Mreported sold
21investors
3Form D filings
2011year on file

Data last updated Oct 23, 2026, 5:45 PM ET · Courts (RECAP) last checked: Oct 24, 2026, 2:34 AM ET · SEC enforcement last checked: covered by the index scan as of Oct 24, 2026, 2:50 AM ET

The short version

Thomas Monath is listed as a director on 3 SEC Form D filings by 3 issuers between Feb 2011 and Oct 2017: VAXINNATE CORP (Cranbury, NJ — biotechnology — 2015; $24.8M reported sold to 14 investors), Xcellerex, Inc. (Marlborough, MA — industry reported as "Other" — 2011; $1.96M reported sold to 3 investors) and US Biologic, Inc. (Memphis, TN — biotechnology — 2017; $1M reported sold to 4 investors).

What this means A repeat sponsor — 3 separate companies raised money with this person listed as director, over about 6 years. Across those companies the filings report $27.8M sold in total.

Listed alongside David Williams (3 shared filings), Augustine Lawlor (1 shared filing), Boris Lipkin (1 shared filing), Chris Przybyszewski (1 shared filing), Douglas Treco (1 shared filing) and 13 others.

What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Thomas. Each name links to their own page.

Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — 1 court case matching the name listed in Key records below.

What this means 1 record came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.

We compared 3 public filings for Thomas Monath and found 6 differences: No amendment in the last 12 months on an offering that may still be open; Same name, different state: "Thomas P. Monath" (MA) is a separate record; and more below.

What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.

What the community is saying

Community search for Thomas Monath has not run yet — it is joining a line of 12,249 names; searches run around the clock at the hosts' allowed rate. Searched so far: 27 names.

Community comments are quoted as written by their authors. Sources searched: BiggerPockets forums (via DuckDuckGo, Brave, Bing and BiggerPockets search) and Reddit (search feed + public archive).

Key records

Five things investors ask first. Items still in human review are counted, not shown.

1. Lawsuits

1 case: 1 judgment

Monath v. Lake Austin Properties I, Ltd. judgment
District Court, M.D. Florida · No. 6:11-cv-01025 · Filed Jun 21, 2011 · Closed Dec 7, 2011 · Nature of suit: 190 Other contract actions
Role of Monath: Plaintiff · Outcome: Terminated 2011-12-07 — FJC Integrated Database disposition: Judgment on motion before trial; judgment for plaintiff Docket on CourtListener ↗
same rare surname (4 people in Form D filings, 3 federal dockets); surname only in the caption; court in FL (not a filing state)
What was searched

Sources searched: CourtListener bulk data (RECAP dockets as of 2026-09-30; recall-first rule 10-24) — federal district + bankruptcy courts State courts: not covered (one-tap state court links under Look further). PACER: not searched. · Last checked Oct 24, 2026, 2:34 AM ET.

Court records show docket facts only; we never restate allegations as facts. Outcome wording comes from the docket feed; where it does not state a disposition we say so.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

2. Regulatory actions

None found in sources searched — SEC enforcement releases (index scan as of Oct 24, 2026, 2:50 AM ET) · state securities regulators: AZ, CA, DE, TX, WA (crawled Oct 23, 2026)

What was searched

SEC enforcement searched: SEC litigation releases and administrative proceedings — respondent names in the sec.gov index titles (30,205 releases, 1995-09-19 to 2026-10-23); release text is read only to confirm a candidate. Names that appear only in the body of a release are not found. — Searched SEC litigation releases and administrative proceedings (1995→ / 2007→) (30,205 records as of Oct 24, 2026, 2:50 AM ET) — nothing matched Thomas Monath..

State securities regulators searched: AZ (Corporation Commission Securities Division), CA (DFPI — 16 of 12,159 DFPI respondent pages read so far; sponsor-name matches are read first), DE (DOJ Investor Protection Unit), TX (State Securities Board), WA (DFI) — last crawled Oct 23, 2026, 9:57 PM ET. Other states are not covered.

3. Bankruptcies

None found in sources searched — federal bankruptcy courts (CourtListener / RECAP), checked Oct 24, 2026

What was searched

Sources searched: Federal bankruptcy courts via CourtListener / RECAP archive (federal district courts, federal bankruptcy courts). State courts: not covered (one-tap state court links under Look further). PACER: not searched (RECAP only). · Last checked Oct 24, 2026, 2:34 AM ET.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

4. Differences between public sources

Comparisons cover issuers and sponsor groups — see the issuer pages under Deals

6 differences found between the filings for Thomas Monath (compared 3 filings on Oct 24, 2026)

Note · Sep 29, 2017 – Oct 13, 2017

No amendment in the last 12 months on an offering that may still be open — US Biologic, Inc. (latest filing Oct 13, 2017)

The latest filing for this offering is dated Oct 13, 2017 (first sale Sep 29, 2017). It reports $1,000,000 sold of $2,000,000 offered. No later amendment is in our index as of Oct 24, 2026.

What this means SEC rules expect a yearly amendment while an offering is still going. The raise may simply have ended — a Form D does not say when it closed. Ask the sponsor whether the offering closed, when, and at what amount.

Sources
Note · Sep 18, 2015 – Sep 28, 2015

No amendment in the last 12 months on an offering that may still be open — VAXINNATE CORP (latest filing Sep 28, 2015)

The latest filing for this offering is dated Sep 28, 2015 (first sale Sep 18, 2015). It reports $3,248,047 sold of $4,341,507 offered. No later amendment is in our index as of Oct 24, 2026.

What this means SEC rules expect a yearly amendment while an offering is still going. The raise may simply have ended — a Form D does not say when it closed. Ask the sponsor whether the offering closed, when, and at what amount.

Sources
Note · Jan 28, 2011 – Feb 4, 2011

No amendment in the last 12 months on an offering that may still be open — Xcellerex, Inc. (latest filing Feb 4, 2011)

The latest filing for this offering is dated Feb 4, 2011 (first sale Jan 28, 2011). It reports $1,956,502 sold of $5,400,000 offered. No later amendment is in our index as of Oct 24, 2026.

What this means SEC rules expect a yearly amendment while an offering is still going. The raise may simply have ended — a Form D does not say when it closed. Ask the sponsor whether the offering closed, when, and at what amount.

Sources
Note · Apr 26, 2012 – Jul 9, 2013

Same name, different state: "Thomas P. Monath" (MA) is a separate record

This page covers filings where the address state is MA or NJ or TN. A separate record, "Thomas P. Monath" with address state MA, is listed on 3 filings — most recently by RAPID MICRO BIOSYSTEMS, INC. (Jul 9, 2013). The two records do not overlap in time: this page has one filing dated Feb 4, 2011; the other runs Apr 26, 2012 to Jul 9, 2013.

What this means Could be the same person who moved, or two people with the same name. We keep them apart until a filing ties them together. Check both pages before you decide.

Sources
Note · Sep 24, 2009 – Oct 26, 2010

Same name, different state: "Thomas P. Monath" (CA) is a separate record

This page covers filings where the address state is MA or NJ or TN. A separate record, "Thomas P. Monath" with address state CA, is listed on 2 filings — most recently by JUVARIS BIO THERAPEUTICS INC (Oct 26, 2010). The two records do not overlap in time: this page has one filing dated Feb 4, 2011; the other runs Sep 24, 2009 to Oct 26, 2010.

What this means Could be the same person who moved, or two people with the same name. We keep them apart until a filing ties them together. Check both pages before you decide.

Sources
Note · Feb 4, 2011 – Oct 13, 2017

Thomas Monath is listed with 3 different address states: MA, NJ, TN

MA on 1 filing (Feb 4, 2011); NJ on 1 filing (Sep 28, 2015); TN on 1 filing (Oct 13, 2017).

What this means The address on a Form D is usually the company's, not the person's home, so this often just reflects different companies. It can also mean a move. Nothing wrong by itself.

Sources
What is compared

What is compared: every Form D and D/A we hold for this subject, side by side — filing dates vs. first-sale dates (the 15-day rule), amendment timing on open offerings (the yearly-amendment expectation), amounts sold, investor counts, offering amounts and minimums across amendments, industry and size bands, addresses, how each person's name and role is written, paid sellers' CRD numbers, and (for groups) where the member companies were formed and sit. Everything is as filed by the issuer; the SEC does not check it. Differences are common and usually have ordinary explanations — we show both values, the dates, and the source so you can ask. As of Oct 24, 2026.

5. Money to insiders

None reported on 3 offerings — no sales commissions, finder's fees or proceeds to insiders

Per-offering detail
Offering (latest filing)Sales commissionsFinder's feesTo insidersPaid to sell itSource
Oct 13, 2017 D
US Biologic, Inc.
File 021-296626
$0$0$0 (est.)
Proceeds of the financing will be applied to working capital needs focused on regulatory approval, product commercialization, and expenses associated with those tasks.
None listed on this filingEDGAR ↗
Sep 28, 2015 D
VAXINNATE CORP
File 021-248311
$0$0$0None listed on this filingEDGAR ↗
Feb 4, 2011 D
Xcellerex, Inc.
File 021-154864
$0$0$0None listed on this filingEDGAR ↗

Counts come from Form D Items 12–15 on the filings in our index (latest filing per offering; one offering = one SEC file number; an amendment updates its offering rather than adding one). "To insiders" = gross proceeds used for payments to executive officers, directors or promoters. "—" = not reported on that filing. Amounts marked (est.) were reported as estimates. "Paid to sell it" = sales compensation recipients named on that filing (Item 12), each linked to FINRA BrokerCheck when a CRD number is reported.

Counted across every filing this person is listed on (latest filing per offering, per issuer).

Deals 3

Every issuer that named Thomas Monath on a Form D, newest first. A Form D is the notice a company files after it starts selling a private investment.

Biotechnology

US Biologic, Inc.

Memphis, TN · Oct 13, 2017
  • Oct 13, 2017 · D · $1,000,000 sold of $2,000,000 · 4 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $1M from 4 investors (50% of the $2M target) as of the latest filing. Thomas is listed as director.

Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

Biotechnology

VAXINNATE CORP

Cranbury, NJ · Sep 28, 2015
  • Sep 28, 2015 · D · $3,248,047 sold of $4,341,507 · 14 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $24.8M from 14 investors (100% of the $4.34M target) as of the latest filing. Thomas is listed as director.

Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

Other

Xcellerex, Inc.

Marlborough, MA · Feb 4, 2011
  • Feb 4, 2011 · D · $1,956,502 sold of $5,400,000 · 3 investors · min. $50 · role: Director EDGAR ↗

Raised $1.96M from 3 investors (36% of the $5.4M target) as of the latest filing. Thomas is listed as director.

Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer.

Other pages with the same name (2)

Separate person records under the same name, not combined with this page. Each line says whether it shares an issuer with this record.

  • Thomas P. Monath — CA, 1 issuer, Sep 24, 2009 → Oct 26, 2010 · no shared issuer
  • Thomas P. Monath — MA, 1 issuer, Apr 26, 2012 → Jul 9, 2013 · no shared issuer

People around Thomas 18

Officers, directors, promoters and management entities named on the same filings, as of Oct 23, 2026, 5:45 PM ET.

DW
No photo found yet (own website and image search run after this page is viewed)
Person

David Williams

Director · 3 shared filings (3 issuers) · also on 1 other issuer

Listed on the same filings as Thomas Monath. Their page shows their other deals.

TS
No photo found yet (own website and image search run after this page is viewed)
Person

Timothy Shannon

Director · 1 shared filing (1 issuer) · also on 9 other issuers

Timothy Shannon is on 10 issuers in total — a repeat sponsor. Their page lists every one.

SW
No photo found yet (own website and image search run after this page is viewed)
Person

Sam Wu

Director · 1 shared filing (1 issuer) · also on 1 other issuer

Listed on the same filings as Thomas Monath. Their page shows their other deals.

SG
No photo found yet (own website and image search run after this page is viewed)
Person

Scot Galliher

Director · 1 shared filing (1 issuer)

Listed on the same filings as Thomas Monath. Their page shows their other deals.

GB
No photo found yet (own website and image search run after this page is viewed)
Person

Guy Broadbent

Executive Officer, Director · 1 shared filing (1 issuer) · also on 3 other issuers

Listed on the same filings as Thomas Monath. Their page shows their other deals.

BL
No photo found yet (own website and image search run after this page is viewed)
Person

Boris Lipkin

Director · 1 shared filing (1 issuer)

Listed on the same filings as Thomas Monath. Their page shows their other deals.

JL
No photo found yet (own website and image search run after this page is viewed)
Person

Jon Lieber

Executive Officer · 1 shared filing (1 issuer) · also on 1 other issuer

Listed on the same filings as Thomas Monath. Their page shows their other deals.

WP
No photo found yet (own website and image search run after this page is viewed)
Person

Wayne Pisano

Executive Officer, Director · 1 shared filing (1 issuer)

Listed on the same filings as Thomas Monath. Their page shows their other deals.

LT
No photo found yet (own website and image search run after this page is viewed)
Person

Lynda Tussey

Executive Officer · 1 shared filing (1 issuer)

Listed on the same filings as Thomas Monath. Their page shows their other deals.

MK
No photo found yet (own website and image search run after this page is viewed)
Person

Mason Kauffman

Executive Officer, Director · 1 shared filing (1 issuer)

Listed on the same filings as Thomas Monath. Their page shows their other deals.

TT
No photo found yet (own website and image search run after this page is viewed)
Person

Tommy Thompson

Director · 1 shared filing (1 issuer)

Listed on the same filings as Thomas Monath. Their page shows their other deals.

CP
No photo found yet (own website and image search run after this page is viewed)
Person

Chris Przybyszewski

Executive Officer, Director · 1 shared filing (1 issuer)

Listed on the same filings as Thomas Monath. Their page shows their other deals.

JZ
No photo found yet (own website and image search run after this page is viewed)
Person

Joseph Zakrzewski

Director · 1 shared filing (1 issuer) · also on 3 other issuers

Listed on the same filings as Thomas Monath. Their page shows their other deals.

PC
No photo found yet (own website and image search run after this page is viewed)
Person

Philippe Chambon

Director · 1 shared filing (1 issuer) · also on 3 other issuers

Listed on the same filings as Thomas Monath. Their page shows their other deals.

DT
No photo found yet (own website and image search run after this page is viewed)
Person

Douglas Treco

Director · 1 shared filing (1 issuer) · also on 3 other issuers

Listed on the same filings as Thomas Monath. Their page shows their other deals.

AL
No photo found yet (own website and image search run after this page is viewed)
Person

Augustine Lawlor

Director · 1 shared filing (1 issuer) · also on 15 other issuers

Augustine Lawlor is on 16 issuers in total — a repeat sponsor. Their page lists every one.

MS
No photo found yet (own website and image search run after this page is viewed)
Person

Michael Shmerling

Director · 1 shared filing (1 issuer) · also on 1 other issuer

Listed on the same filings as Thomas Monath. Their page shows their other deals.

KM
No photo found yet (own website and image search run after this page is viewed)
Person

Kathleen A. McGowan

Executive Officer · 1 shared filing (1 issuer)

Listed on the same filings as Thomas Monath. Their page shows their other deals.

The team behind the deals

Registrations and other filings

Adviser registration (Form ADV)

None of the 3 issuers this person is listed on appears in Form ADV (searched 24,962 advisers as of Oct 2, 2026). A person is never an adviser firm; Form ADV is checked for the issuers and the management companies they are listed with.

Other offering types (Regulation A and Regulation Crowdfunding)

Searched SEC Regulation A Data Sets (Forms 1-A, 1-K, 1-Z; 2015 Q2 → 2026 Q3); SEC Crowdfunding Offerings Data Sets (Form C family; 2016 Q2 → 2026 Q3); EDGAR form index for 2026 Q3 → 2026 Q4 (51,358 records as of Oct 23, 2026, 8:41 PM ET) — nothing matched this name.

Property records none — individuals are not matched

Property records are matched to companies only, never to individuals, so none are matched to Thomas Monath by design. Searched property records in Hillsborough County FL (Clerk recorded-document index Oct 14, 2026 to Oct 15, 2026 + FL DOR 2026 ownership roll), Miami-Dade County FL (FL DOR 2026 ownership roll), Harris County TX (HCAD 2026 ownership roll), Dallas County TX (DCAD 2026 ownership roll), New York City ACRIS documents and PLUTO ownership rows already retrieved for other issuers, Cook County IL sale and ownership rows already retrieved for other issuers (814,874 records as of Oct 23, 2026, 8:59 PM ET) for the 3 issuers this person is listed on — nothing matched.

Public profiles and social

Websites and social links of the issuers Thomas Monath is listed on: none on file. No website or social profile named in VAXINNATE CORP's SEC filings (Form C, Reg A, Form ADV; checked Oct 24, 2026). Web search for this name: #298,372 of 374,652 in line (14 issuers searched so far). One-tap searches: Look further ↓

Look further

One-tap searches on sites we do not index ourselves, with the name pre-filled (Cranbury, NJ). Each opens in a new tab; what you find there is not verified by PartnerFacts.

Change history

No corrections have been requested for this page.

Every fact links to its public-record source. Plain-English notes next to a fact are our reading of that fact, not a rating. Request a correction · Facts policy

Request a correction

Free. Logged with status: received → under review → fixed / confirmed with source.

Add a response

If this is you or your firm, add a sourced explanation next to any fact. Reviewed before publishing.

Monitor this person

Members get an email when Thomas Monath appears on a new Form D, or when a court case or SEC action is matched to them. See plans →